Boston Scientific vs Koninklijke Philips NV
Boston Scientific and Koninklijke Philips NV are similar in size: $20.07bn and $20.16bn of revenue in their latest fiscal years. Boston Scientific grew faster (19.9% against 3.4%). Boston Scientific kept more of each dollar of sales as profit: a net margin of 14.4% against 5.0%. Boston Scientific carries less debt relative to equity (47.2% against 73.8%).
| Latest fiscal year | Boston ScientificBSX, 2025 | Koninklijke Philips NVPHG, 2025 |
|---|---|---|
| Revenue | $20.07bn | $20.16bn |
| Revenue growth | 19.9% | 3.4% |
| Net income | $2.90bn | $1.01bn |
| Operating margin | 18.0% | 8.0% |
| Net margin | 14.4% | 5.0% |
| Return on equity | 12.6% | 8.0% |
| Free cash flow | $3.66bn | — |
| Cash | $1.97bn | $3.28bn |
| Total debt | $11.44bn | $9.49bn |
| Debt to equity | 47.2% | 73.8% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $0 |
| Employees | 59,000 | — |
| Market value | $63.03bn | $27.46bn |
| Price vs our value range | Within our value range | — |
| Moat score | 73 (Strong) | — |
| Insider trades, 12 months | 10 buys, 7 sales | 0 buys, 0 sales |